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Background: Panax ginseng has distinct and impressive health beneﬁts, such as improved blood pressure
and immune system functioning. Rg3-enriched Korean Red Ginseng (REKRG) isolated from Korean Red
Ginseng contains a high percentage of Rg3.
Methods: In this study, we examined the effects of REKRG on endothelial cell nitric oxide synthase
(eNOS) activation and adhesion molecules in endothelial cells and vascular function in rats.
Results: REKRG dose-dependently increased eNOS phosphorylation and nitric oxide (NO) production in
endothelial cells. In addition, REKRG markedly inhibited the tumor necrosis factor-a (TNF-a)-mediated in-
duction of intercellular adhesionmolecule (ICAM)-1 and cyclooxygenase (COX)-2 expressions in endothelial
cells. REKRG improved endothelium-dependent vasorelaxation in the Wistar-Kyoto (WKY) rat and sponta-
neously hypertensive rats (SHRs) compared with controls. Furthermore, REKRG treatment for 6 weeks
increased serum NO levels and reduced the mean aortic intima-media thickness compared with controls.
Conclusion: Taken together, these results suggest that REKRG increased vascular function and improved
immune system functioning. Therefore, REKRG is a very useful food for preventing or improving various
cardiovascular diseases.
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Hypertension is one of the major risk factors for the develop-
ment of cardiovascular disease and modulation of the immune
system [1,2] and is characterized by impaired vascular endothelial
function [2e4]. Vascular endothelial cells are located in the intima,
which is the inner lining of the vasculature, and they play an
important role in the regulation of vascular tone by various vaso-
active factors, such as nitric oxide (NO) [5]. Disruption of endo-
thelial cell function is characterized by impaired bioavailability of
NO [2,6] and induces vascular disease, which in turn contributes to
smooth muscle cell proliferation [7] and stimulation of inﬂamma-
tory molecules, such as intercellular adhesion molecule (ICAM)-1,Chungnam National University Ho
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e Korean Society of Ginseng, Publvascular cell adhesion molecule (VCAM)-1, and cyclooxygenase
(COX)-2. NO is a major endothelium-dependent relaxing factor. It is
produced from L-arginine by the activity of endothelial cell nitric
oxide synthase (eNOS) [8] and induces vascular smooth muscle
relaxation by activation of guanylate cyclase [9]. Some studies have
shown that blood pressure was enhanced in eNOS knockout mice
[10,11] as well as in rats in which eNOS was inhibited with Nu-
nitro-L-arginine methyl ester (L-NAME) [12]. It was also reported
that the bioavailability of NO was reduced in patients with estab-
lished hypertension compared with the control group [2,6].
For thousands of years, Panax ginseng has been used as a
traditional tonic medicine. The protective effects of P. ginseng
related to cardiovascular functions are reportedly associated withspital, Daejeon 301-712, Korea.
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Ginsenosides consist of twomajor groups according to the chemical
structure of the fraction. The ﬁrst is the panaxadiol group, which
includes Rb1, Rb2, Rb3, Rc, Rd, Rg3, Rh2, and Rs1. The second is the
panaxatriol group, which includes Re, Rf, Rg1, Rg2, and Rh1. Indi-
vidual ginsenosides exert different effects via different mechanisms
in various tissues. The combination of ginsenosides in ginseng ex-
tracts may be important for providing more powerful therapeutic
and pharmacological effects [15e17]. Notably, ginsenoside Rg3
provides various protective effects, including anti-inﬂammatory
[18] and antitumor effects [19], and it also enhances NO production
and eNOS activity [20].
The aim of this study was to investigate whether Rg3-enriched
Korean Red Ginseng (REKRG), a ginsenoside fraction enriched in
Rg3, increases eNOS activity and NO production and exhibits anti-
inﬂammatory effects.
2. Materials and methods
2.1. Preparation of ginsenoside Rg3-enriched Korean Red Ginseng
Dried Korean Red Ginseng (P. ginseng) root was purchased from
Gumsan Nonghyup (Gumsan, Korea). Korean ginseng was extracted
two timeswith 10 volumes of ethanol at 50C for 7 hours (1st 50%, 2nd
85%), and then concentratedunder vacuumat50C. The crude extract
was dissolved in water and enzyme-acid hydrolysis to maximize
ginsenoside Rg3 was performed (raw ginsenoside was hydrolyzed to
Rg3) in acidic (pH 2.5w3.5) and thermophilic (65w80C) condition.
The enzyme, which has b-glycosidase activity including cellulase,
hemicellulose, and glucosidase activity, was produced by Aspergillus
niger. To remove acid solution and concentrate Rg3, the reactant was
passed through DIAION HP20 resin (Mitsubishi Chemical Industries,
Tokyo, Japan) packed column. The ginsenoside Rg3was concentrated
to powder under vacuumconditions. Itwas kindly provided by BTGin
Corporation (Occheon, Korea).
2.2. High-performance liquid chromatography analysis
The powder was dissolved in 70% methanol, and ginsenosides
including Rg3 was analyzed by high-performance liquid chroma-
tography (HPLC). HPLC was carried out on an Liquid chromatog-
raphy (LC) system equipped with a quaternary gradient pump
(Spectra 4000) and UV detector (Spectra 2000; Thermo Scientiﬁc,
San Jose, CA, USA). A reversed-phase column (Hypersil gold C18,
100 mm 4.6 mm, internal diameter 5 mm; Thermo Scientiﬁc) was
used for quantitative determination of ginsenosides Rg3. The mo-
bile phase consisted of acetonitrile and water with a ﬂow rate at
1.6e2.5 mL/min, and the column was kept at room temperature.
The detection wavelength was set at 203 nm.
2.3. Cell culture
Humanumbilical vein endothelial cells (HUVECs)were purchased
from Clonetics (San Diego, CA, USA) and cultured in Endothelial
Growth Medium-2 from Lonza (Walkersville, MD, USA). Subcon-
ﬂuent, proliferating HUVECs were used between passages 2 and 8.
2.4. Animals and experimental protocols
The Animal Care Committee of Chungnam National University
approved the animal care and all experimental procedures con-
ducted in this study. All instrumentation was used under aseptic
conditions. Male Wistar rats and spontaneously hypertensive rats
(SHRs; 3 months old) were each divided into two groups (n ¼ 5)randomly: a normal saline group and a REKRG group. REKRG
(10 mg/kg) was orally administered to animals for 6 weeks.
2.5. Antibodies and Western blotting
Anti-ICAM-1, anti-eNOS, and anti-COX-2 antibodies were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Antiphospho-eNOS, antiphospho-Akt, and anti-Akt antibodies
were purchased from Cell Signaling Technology (Beverly, MA, USA).
Western blot analysis of whole cell lysates (30 mg) was performed
using the appropriate primary and secondary antibodies. Blots
were imaged using a chemiluminescence assay kit from Pharmacia-
Amersham (Freiburg, Germany), and band densities were quanti-
ﬁed using a Gel Doc 2000 ChemiDoc system and Quantity One
software from Bio-Rad (Hercules, CA, USA). Values were normal-
ized to a b-actin loading control.
2.6. Real-time polymerase chain reaction
Total RNA was isolated from cells using the acid guanidinium
thiocyanateephenolechloroform method. Real-time polymerase
chain reaction (PCR) was performed using the Prism 7000 Sequence
Detection System (Applied Biosystems, Foster City, CA, USA) with
the Super Script III Platinum SYBR Green One-Step qRT-PCR Kit
(Invitrogen, Carlsbad, CA, USA). Primers used to amplify human
ICAM-1 were as follows: 50-CAGTGACCATCTACAGCTTTCCG-30 and
50-GCTGCTACCACAGTGATGATGACAA-30. Primers used for human
COX-2 were as follows: 50-GGTCTGGTGCCTGGTCTGATGATG-30 and
50-GTCCTTTCAAGGAGAATGGTGC-30. Primers used for human glyc-
eraldehyde3-phosphatedehydrogenase (GAPDH),whichwasusedas
an internal control, were as follows: 50-ATGACATCAAGAAGGTGGTG-
30 and 50-CATACCAGG AAAATGAGCTTG-30. Dissociation curves were
monitored to check for aberrant formation of primer-dimers.
2.7. Nitrite and nitrate measurements
The NO metabolites nitrite (NO2) and nitrate (NO3), the stable
breakdown products of NO, were quantiﬁed using a commercially
available kit (Nitrate/Nitrite Fluorometric Assay Kit, Cayman
Chemicals, Lexington, KY, USA), as per the manufacturer’s in-
structions. Medium and blood plasma were deproteinized using a
10-kDa cutoff ﬁlter (Microcon YM10, Millipore, Billerica, MA, USA).
After subtraction of background ﬂuorescence, the total protein
amounts were determined from the normalized values.
2.8. Vascular reactivity
Wistar-Kyoto (WKY) rats and SHRs were sacriﬁced via sodium
pentobarbital overdose.Amid-sternal splitwasperformedquickly, and
the descending thoracic aorta excised carefully and placed in ice-cold
Krebsbuffer (118.3mMNaCl, 4.7mMKCl, 2.5mMCaCl2,1.2mMKH2PO4,
25mM NaHCO3, 1.2mM MgSO4, 11mM glucose, 0.0026mM CaNa2
EDTA). The aortawas cleanedof excess fat and cut transversely into 5e
10 rings (2.0e3.0 mm). Endothelium-dependent vasorelaxation was
measured by the aortic rings as described previously [21].
2.9. Histology
A 1.5-cm section of the ascending thoracic aorta was dissected
from the heart. Parafﬁn sections were cut (5 mm) and stained with
hematoxylin and eosin. The mean values of the vessel wall thickness
and cross sectional area from the endothelial surface to the adventitia
were determined from digitalized microphotographs using com-
mercial imaging analysis software (Axio Scope software, Thornwood,
NY, USA).
Fig. 1. High-performance liquid chromatography (HPLC) chromatograms of Korean Red Ginseng and Rg3 enriched Korean Red Ginseng. (1) Rg1. (2) Re. (3) Rf. (4) Rh1(S). (5) Rh1(R)þ
Rg2(S). (6) Rg2(R). (7) Rb1. (8) Rc. (9) Rb2. (10) Rg3(S). (11) Rg3(R). (12) Rk1. (13) Rg5.
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All experiments were performed at least three times. Statistical
analysis was performed according to the SPSS version 13.0 (SPSS
Inc., Chicago, IL, USA). Data are presented as the mean  standard
deviation. Statistical signiﬁcance was determined using analysis of
variance (ANOVA) followed by a multiple comparison test with a
Bonferroni adjustment and by p < 0.05.
3. Results
3.1. Comparison of HPLC chromatograms REKRG and KRG
11 ginsenosides (Rg1, Re, Rf, Rh1, Rg2, Rb1, Rc, Rb2, Rg3, Rk1, and
Rg5) were analyzed by HPLC. HPLC chromatograms of REKRG and
KRG are shown in Fig. 1. The amount of Rg1, Re, Rf, Rh1, Rg2, Rb1, Rc,
Rb2, Rg3, Rk1, and Rg5was 0.6,1.9,12.3, 5, 4.2, 3.8,1.2,1,100,12, and
21 in REKRG and 2.9, 4.2, 0.3, 0.1, 0.2, 5.9, 2.2, 2.1, 0.3, 0.05, and 0.12
in KRG. These results show that the concentration of ginsenoside
Rg3 in REKRG is w300 times greater than in KRG (Table 1).
3.2. REKRG stimulates the phosphorylation of Akt and eNOS and
increases NO production in HUVECs
Because Rg3 enhances eNOS phosphorylation and NO production
[20],wenextexaminedwhetherREKRGhasaneffectonAkt andeNOS
activation in endothelial cells. HUVECswere incubatedwith0.1e1mg/Table 1
The saponin contents in Rg3-enriched Korean Red Ginseng and Korean Red Ginseng (mg
Rg1 Re Rf Rg2 Rh1 Rb1
REKRG 0.6 1.9 12.3 5 4.2 3.87
KRG 2.9 4.2 0.3 0.1 0.2 5.9mL REKRG for 24 hours. Cells were then harvested and processed for
Western blot analysis. REKRG concentration-dependently stimulated
Ser-437 phosphorylation of Akt and Ser-1177 phosphorylation of
eNOS (Fig. 2A, 2B).Wealso examinedNOlevels in the culturemedium
after HUVECs were exposed to 0.1e1 mg/mL REKRG for 24 hours. NO
levels were increased compared with control (Fig. 2C). These results
showthatREKRGstimulates theAkt/eNOSsignalingpathway, leading
to increased NO production in endothelial cells.
3.3. REKRG inhibits ICAM-1 and COX-2 expression induced by TNF-
a in HUVECs
It is well known that Rg3 has an anti-inﬂammatory effect [18].
Therefore, we next examined the effect of REKRG on TNF-a-induced
increases in ICAM-1andCOX-2expression inHUVECs.TNF-a increased
ICAM-1 and COX-2 expression at both the protein andmessenger RNA
(mRNA) levels in HUVECs (Fig. 3A, 3B). However, the TNF-a-induced
increases in VCAM-1 and COX-2 expression at the protein and mRNA
levels in HUVECs were blunted by REKRG in a concentration-depen-
dent manner (Fig. 3A, 3B), suggesting that REKRG can inhibit inﬂam-
matory proteins and possibly the early stage of atherosclerosis.
3.4. REKRG improves impaired endothelial-dependent vascular
relaxation in the aorta in SHRs
Many studies have shown that various ginsenosides, including
Rg3, have a beneﬁcial effect on vascular function [20]. Therefore, we/g)
Rc Rb2 Rg3(S) Rg3(R) Rk1 Rg5
1.2 1 45 55 12 21
2.2 2.1 0.2 0.1 0.05 0.12
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tion in rat aortic rings. Acetylcholine-induced relaxation was
measured in the presence of REKRG in an organ bath. In WKY rat
aortic rings, endothelium-dependent vasorelaxation was not
affected by 1 mg/mL REKRG treatment (Fig. 4A). However, compared
with control rings, 1 mg/mL REKRG treatment improved impaired
endothelium-dependent vasorelaxation in SHR aortic rings
(Fig. 4B).
3.5. REKRG increases serum NO levels and reduces aortic intima-
media thickness in SHRs
REKRG (10 mg/kg) was administered to rats for 6 weeks by
gastric gavage. We next examined the effect of REKRG on serum NO
levels. Compared with controls, 10 mg/kg REKRG increased serum
NO levels in SHRs (Fig. 5A).
NO inhibits smooth muscle cell migration and proliferation [7];
therefore, we next examined the vascular structure is changed by
REKRG in SHR. Digitalized microphotographs of histological sec-
tions were used to measure vessel wall thickness and cross
sectional area (Fig. 5B, 5C). The aortic intima-media thickness and
cross-sectional area in SHR were signiﬁcantly thicker than it in
WKY. Interestingly, REKRG administration for 6 weeks resulted in
decreased aortic intima-media thickness and cross sectional area in
SHRs, suggesting that chronic administration of REKRGmay change
vascular tone and structure.
4. Discussion
High blood pressure produces chronic stress in the body and is a
major risk factor for vascular disease. It is associated withFig. 2. The effect of Rg3-enriched Korean Red Ginseng (REKRG) on endothelial nitric oxide sy
phosphorylation of Akt and eNOS was increased dose-dependently in HUVECs treated with
and subjected to Western blot analysis for p-eNOS (upper panels). b-actin is shown as a load
panels of A and B). Western blots are representative of three independent experiments. *p <
increased nitric oxide (NO) production. Metabolites of NO (nitrite and nitrate) were measur
untreated cells. Data are presented as mean  standard deviation (n ¼ 3).morphological alteration and dysfunction of vascular endothelial
cells, which can lead to atherosclerosis. The protective effects of
ginseng and ginsenosides have been widely studied and shown to
have new beneﬁcial effects on hypertension [14] and various dis-
eases, such as atherosclerosis, cancer, and thrombosis [19,22e24].
In this study, we showed that REKRG increases NO production and
induces endothelium-dependent vasorelaxation in aortic rings
from SHRs. Furthermore, REKRG administration via gastric gavage
increased serum NO levels and reduced blood pressure and aortic
intima-media thickness.
It is unclear whether absorption of intact ginsenosides can take
place in the human gastrointestinal tract and whether their hy-
drolysis products, protopanaxadiol (PPD) and protopanaxatriol
(PPT), reach the systemic circulation. Pharmacokinetic analysis of
Rg3 showed that the time to reach the peak plasma concentration
after oral administration was 150.0  73.5 h [25]. The data showed
that the oral bioavailability of Rg3 was 2.63, which limits its
beneﬁcial effect. Furthermore, the amount of Rg3 in Korean Red
Ginseng is usually less than 0.5%, even when steam heat treatment
of ginseng roots, which strongly increases the amount of Rg3, is
used. Therefore, in order to improve the biodistribution of Rg3 in
vivo, we used REKRG, a ginsenoside fraction containing a high
percentage of Rg3 isolated from P. ginseng, in this study.
NO fromvascular endothelial cells plays an important role in the
regulation of vascular function, as well as in inhibition of platelet
aggregation and adhesion to the endothelium [26]. In addition,
endothelium-derived NO inhibits not only smooth muscle cell
proliferation but also migration to form the neointima. It is well
known that the reduction in blood pressure by Korean Red Ginseng
may be mediated by vascular endothelial cell-derived NO, and that
Korean Red Ginseng promotes NO production in vascularnthase (eNOS) activation in human umbilical vein endothelial cells (HUVECs). (A,B) The
various concentrations (0.1e1 mg/mL) of REKRG for 24 hours. The cells were harvested
ing control. p-eNOS expression levels were quantiﬁed by densitometric analysis (lower
0.05, **p < 0.01 compared with untreated cells. (C) REKRG treatment dose-dependently
ed in the media of HUVECs treated with 0.1e1 mg/mL REKRG. *p < 0.05 compared with
Fig. 3. The effect of Rg3-enriched Korean Red Ginseng (REKRG) on the expression of intercellular adhesion molecule (ICAM)-1 and cyclooxygenase (COX)-2 induced by tumor
necrosis factor-a (TNF-a) in human umbilical vein endothelial cells (HUVECs). (A) and (C) REKRG dose-dependently inhibited TNF-a-induced ICAM-1 and COX-2 protein expression
in HUVECs. Cells were pretreated with various concentrations (0.1e1 mg/mL) of REKRG for 30 minutes and then treated with 15 ng/mL TNF-a for 8 hours in the presence of REKRG.
The cells were harvested and subjected to Western blot analysis for ICAM-1 (upper panel of A) and COX-2 (upper panel of C). b-actin is shown as a loading control. The levels of
ICAM-1 and COX-2 were quantiﬁed by densitometric analysis (lower panel of A and C). All Western blots shown are representative of three independent experiments. *p < 0.05
compared with control cells. (B,D) REKRG dose-dependently inhibited TNF-a-induced ICAM-1 and COX-2 mRNA expression in HUVECs. *p < 0.05 compared with untreated cells.
Data are presented as mean  standard deviation (n ¼ 3).
J Ginseng Res 2014;38:244e250248endothelial cells [13,14]. Korean Red Ginseng induces angiogenesis
by activating PI3K/Akt-dependent extracellular signal-regulated
kinase 1/2 and eNOS pathways in HUVECs [27]. The ginsenoside Re
activates potassium channels of vascular smooth muscle cellsFig. 4. The effects of Rg3-enriched Korean Red Ginseng (REKRG) on vascular tone. (A) RE
(WKY) rats. (B) REKRG treatment improved impaired endothelium-dependent vasorelaxatio
aortic rings with REKRG (1 mg/mL) for 30 min. *p < 0.05 compared with untreated aortic rthrough PI3k/Akt and NO pathways [28]. Moreover, the ginsenoside
Rg3 increases NO production through the PI3K/Akt pathway [20].
This can lead to stimulation of eNOS phosphorylation and expres-
sion in ECV-304 endothelial cells [20] and inhibition of TNF-a-KRG treatment did not affect endothelium-dependent vasorelaxation in Wistar-Kyoto
n in rats. Endothelium-dependent vasorelaxation was assessed after pre-treatment of
ings. Data are presented as mean  standard deviation (n ¼ 4e5).
Fig. 5. The effect of Rg3-enriched Korean Red Ginseng (REKRG) on aortic structure. (A) REKRG treatment increased nitric oxide (NO) production. Metabolites of NO (nitrite and
nitrate) were measured in the serum. *p < 0.05 compared with control. Data represent the mean  standard deviation (SD; n ¼ 4e5). (B,C) The intima-media thickness and cross
sectional area were quantiﬁed using a computer-assisted imaging device. The mean value of the vessel wall thickness from the endothelial surface to the adventitia was determined
from ﬁve different locations spanning the entire cross-section. *p < 0.05 compared with Wistar-Kyoto rats. **p < 0.05 compared with SHR. Data represent the mean  SD (n ¼ 5e6).
(D) Representative images of hematoxylin and eosin-stained aortic rings.
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and ICAM-1, in human endothelial cells [18]. Our results also
showed that REKRG not only stimulates eNOS phosphorylation and
NO production but also decreases VCAM-1 and COX-2 expression.
These ﬁndings suggest an important role for Rg3-enriched ginseng
extract in vascular protection.
In conclusion, this study showed that the stimulatory effect of
REKRG administration on vascular endothelial NO production
through phosphorylation of eNOS is likely to have relevance for not
only inhibition of VCAM-1 and COX-2 expression but also decreased
aortic intima-media thickness, which improves cardiovascular
function and prevents atherosclerosis.Conﬂict of interest
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